BALTIMORE — The anti-interleukin-6 (IL-6) antibody drug tocilizumab shows efficacy in the treatment of patients with autoimmune limbic encephalitis (ALE) who do not respond to rituximab, new research ...

Catholic nuns don't make a habit of participating in long-term studies on aging and dementia, but one notable exception has yielded critical insights into cognitive resilience, neuropathology and ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Older adults are increasingly being diagnosed with limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia. This is in part due to new guidelines advising doctors how to identify the ...

Proposed clinical criteria for a memory loss disorder that is often misdiagnosed as Alzheimer's disease (AD), have been published. The new criteria for limbic-predominant amnestic neurodegenerative ...

The patient received a diagnosis of myasthenia gravis (MG), then underwent a medical odyssey as physicians attempted to pin down the cause of his neurological symptoms. Myasthenia gravis (MG) and ...